N
#PancreaticCancer #EarlyDetection #CancerResearch
www.nih.gov
Researchers identify new blood markers that may detect early pancreatic cancer
NIH-funded, four-marker panel could one day help catch one of deadliest cancers at more treatable stages.
National Institutes of Health (NIH)-supported investigators have developed a blood test to find pancreatic ductal adenocarcinoma, one of the deadliest forms of cancer.
#PancreaticCancer #MedicalBreakthrough #CancerResearch
www.newsweek.com
Did scientists find pancreatic cancer cure? What to know about breakthrough
A major medical breakthrough might have been achieved while researching an eventual cure for pancreatic cancer, as a new study from scientists in Spain discovered that triple therapy could entirely eliminate it in mice.
#PancreaticCancer #CancerResearch #Immunotherapy
www.yahoo.com
Scientists may have found key to treating hidden cancer growths
Add Yahoo as a preferred source to see more of our stories on Google.
Scientists may have discovered the way in which pancreatic cancer - dubbed the "silent killer" - hides from the immune system, and how disrupting this process could help tumours to shrink.
#PancreaticCancer #HealthAwareness #SelfAdvocacy
www.newsweek.com
Mom thinks supplements are causing abdominal pain -- then gets shock diagnosis
A mom who lived with severe abdominal pain for months thought it was related to digestion, and she tried everything to improve her gut -- but nothing could prepare her for what a CT scan would later reveal.
#PancreaticCancer #CancerResearch #ClinicalTrials
markets.businessinsider.com
HUTCHMED Initiates Phase III Stage of the Ongoing Trial of the Combination of Surufatinib and Camrelizumab for Treatment-Na茂ve Pancreatic Ductal Adenocarcinoma
HONG KONG and SHANGHAI and FLORHAM PARK, N. J. , Jan. 05, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated the Phase III part of the Phase II/III trial to evaluate the efficacy of the combination of surufatinib, camrelizumab, nab-paclitaxel and gemcitabine as a first-line treatment for patients with metastatic pancreatic ductal adenocarcinoma ("PDAC") in China.
C
#CancerResearch #PancreaticCancer #ClinicalTrials
www.courant.com
Pancreatic cancer is among the deadliest cancers. A new drug being tested at Penn is giving patients and doctors hope
PHILADELPHIA -- Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to stage 4 less than a year after her initial diagnosis.
